vs
CS Disco, Inc.（LAW）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是CS Disco, Inc.的1.7倍（$69.8M vs $41.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -20.7%，领先404.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 11.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.6%）
CS Disco, Inc.是一家领先的法律科技企业，开发面向法律从业者的云原生软件产品，涵盖电子取证、文档审核、案件管理及法律工作流自动化等工具，服务客户包括律师事务所、企业法务部门及政府法律机构。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LAW vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$41.2M
营收增速更快
RIGL
高出9.9%
11.3%
净利率更高
RIGL
高出404.7%
-20.7%
两年增速更快
RIGL
近两年复合增速
7.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.2M | $69.8M |
| 净利润 | $-8.5M | $268.1M |
| 毛利率 | 75.1% | 91.5% |
| 营业利润率 | -22.4% | 33.2% |
| 净利率 | -20.7% | 384.0% |
| 营收同比 | 11.3% | 21.2% |
| 净利润同比 | 66.3% | 1769.2% |
| 每股收益（稀释后） | $-0.13 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LAWRIGL
| Q4 25 | $41.2M | $69.8M | ||
| Q3 25 | $40.9M | $69.5M | ||
| Q2 25 | $38.1M | $101.7M | ||
| Q1 25 | $36.7M | $53.3M | ||
| Q4 24 | $37.0M | $57.6M | ||
| Q3 24 | $36.3M | $55.3M | ||
| Q2 24 | $36.0M | $36.8M | ||
| Q1 24 | $35.6M | $29.5M |
净利润LAWRIGL
| Q4 25 | $-8.5M | $268.1M | ||
| Q3 25 | $-13.7M | $27.9M | ||
| Q2 25 | $-10.8M | $59.6M | ||
| Q1 25 | $-11.4M | $11.4M | ||
| Q4 24 | $-25.2M | $14.3M | ||
| Q3 24 | $-9.2M | $12.4M | ||
| Q2 24 | $-10.8M | $-1.0M | ||
| Q1 24 | $-10.6M | $-8.2M |
毛利率LAWRIGL
| Q4 25 | 75.1% | 91.5% | ||
| Q3 25 | 75.5% | 93.2% | ||
| Q2 25 | 74.6% | 95.6% | ||
| Q1 25 | 74.1% | 91.7% | ||
| Q4 24 | 74.2% | 89.9% | ||
| Q3 24 | 73.1% | 85.5% | ||
| Q2 24 | 74.2% | 92.4% | ||
| Q1 24 | 75.1% | 93.1% |
营业利润率LAWRIGL
| Q4 25 | -22.4% | 33.2% | ||
| Q3 25 | -35.3% | 40.9% | ||
| Q2 25 | -31.0% | 60.1% | ||
| Q1 25 | -34.4% | 23.9% | ||
| Q4 24 | -70.6% | 28.9% | ||
| Q3 24 | -30.0% | 25.4% | ||
| Q2 24 | -34.4% | 1.2% | ||
| Q1 24 | -34.7% | -23.6% |
净利率LAWRIGL
| Q4 25 | -20.7% | 384.0% | ||
| Q3 25 | -33.4% | 40.2% | ||
| Q2 25 | -28.4% | 58.6% | ||
| Q1 25 | -31.1% | 21.5% | ||
| Q4 24 | -68.1% | 24.9% | ||
| Q3 24 | -25.3% | 22.5% | ||
| Q2 24 | -30.1% | -2.8% | ||
| Q1 24 | -29.7% | -27.9% |
每股收益（稀释后）LAWRIGL
| Q4 25 | $-0.13 | $14.11 | ||
| Q3 25 | $-0.22 | $1.46 | ||
| Q2 25 | $-0.18 | $3.28 | ||
| Q1 25 | $-0.19 | $0.63 | ||
| Q4 24 | $-0.43 | $0.82 | ||
| Q3 24 | $-0.15 | $0.70 | ||
| Q2 24 | $-0.18 | $-0.06 | ||
| Q1 24 | $-0.17 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $114.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $128.1M | $391.5M |
| 总资产 | $173.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LAWRIGL
| Q4 25 | $114.6M | $155.0M | ||
| Q3 25 | $113.5M | $137.1M | ||
| Q2 25 | $114.5M | $108.4M | ||
| Q1 25 | $118.8M | $77.1M | ||
| Q4 24 | $129.1M | $77.3M | ||
| Q3 24 | $126.8M | $61.1M | ||
| Q2 24 | $130.0M | $49.1M | ||
| Q1 24 | $148.7M | $49.5M |
总债务LAWRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益LAWRIGL
| Q4 25 | $128.1M | $391.5M | ||
| Q3 25 | $130.6M | $117.6M | ||
| Q2 25 | $137.9M | $81.9M | ||
| Q1 25 | $142.2M | $18.6M | ||
| Q4 24 | $147.5M | $3.3M | ||
| Q3 24 | $167.3M | $-14.6M | ||
| Q2 24 | $170.9M | $-29.9M | ||
| Q1 24 | $193.2M | $-31.7M |
总资产LAWRIGL
| Q4 25 | $173.6M | $513.6M | ||
| Q3 25 | $174.8M | $242.5M | ||
| Q2 25 | $164.9M | $206.7M | ||
| Q1 25 | $168.0M | $176.0M | ||
| Q4 24 | $180.3M | $164.0M | ||
| Q3 24 | $194.4M | $139.4M | ||
| Q2 24 | $198.0M | $128.4M | ||
| Q1 24 | $217.3M | $126.5M |
负债/权益比LAWRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $762.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $255.0K | — |
| 自由现金流率自由现金流/营收 | 0.6% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-18.0M | — |
8季度趋势，按日历期对齐
经营现金流LAWRIGL
| Q4 25 | $762.0K | $22.0M | ||
| Q3 25 | $-979.0K | $24.0M | ||
| Q2 25 | $-4.2M | $30.5M | ||
| Q1 25 | $-10.5M | $-893.0K | ||
| Q4 24 | $2.1M | $14.5M | ||
| Q3 24 | $-2.9M | $21.7M | ||
| Q2 24 | $-650.0K | $302.0K | ||
| Q1 24 | $-7.3M | $-5.0M |
自由现金流LAWRIGL
| Q4 25 | $255.0K | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-5.2M | — | ||
| Q1 25 | $-11.0M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-8.0M | — |
自由现金流率LAWRIGL
| Q4 25 | 0.6% | — | ||
| Q3 25 | -5.0% | — | ||
| Q2 25 | -13.6% | — | ||
| Q1 25 | -30.1% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | -10.3% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | -22.5% | — |
资本支出强度LAWRIGL
| Q4 25 | 1.2% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.9% | — |
现金转化率LAWRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAW
| Software | $35.1M | 85% |
| Services | $6.0M | 15% |
RIGL
暂无分部数据
